Physician profile
Larry S Nichter
NPI 1710062336
$8,129.68
in general payments reported to CMS, 2019-2025
16 companies · $2,690 in 2025
The $2,690 reported for 2025 was more than what 89% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $820 · 2020: $341 · 2021: $722 · 2022: $1,255 · 2023: $829 · 2024: $1,473 · 2025: $2,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,938 · Grant: $1,750 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,279 · Education: $25.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,937.72 |
| Grant | $1,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,279.08 |
| Education | $25.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,330.90 | 2023-2025 | |
| Allergan, INC. | $1,239.47 | 2019-2022 | |
| Sientra, INC. | $1,153.32 | 2019-2022 | |
| Mentor Worldwide LLC | $398.90 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Kerecis Limited | $254.05 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $160.10 | 2022-2024 | Exparel |
| Davol INC. | $130.81 | 2022 | |
| Tela Bio, INC. | $95.14 | 2021-2022 | |
| Merz North America, INC. | $90.02 | 2022 | |
| Motiva USA, LLC | $86.69 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $73.30 | 2020 | |
| Apyx Medical Corporation | $33.64 | 2019 | |
| Galderma Laboratories, L.P. | $29.46 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $21.11 | 2019 | |
| Tepha INC | $18.86 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $13.91 | 2023 | Dsuvia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Nichter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.